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. The perpre of this study was to prospectively
eve the this of vascular event In patients with protruding
evade s in ease .
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Beieb. Of 42 patients wish otherness. 14 (33%) had 19
mamba event dining
follow-up (5 brain, 2 eye, 4 Iddaey,
Retrospective studies have documented the association be-
tween Protruding atheronas in the thoracic aorta and
cm-
belle disease (1-4). Embolic syndromes reported in patients
with each sehmamas may involve the brain or the systemic
circulation . They may be either spontaneous or imragosnic .
antedated with cardiac cathetezisatitin and asgiography
(1,3.5). intraaortie balloon pump insertion (5) and cannula-
tion of the aorta for die institution of cardiopulmonary
bypass (6). Because of the inherent limitations of retrospec-
tive anagmis, even with acase-conhol design (2) . the current
study was undertaken to evaluate the risk of future vascular
events m patients who were found to have protruding aortic
atherras diagnosed by trawsesephageal echocardiogrmphy .
Methods
t411e tu. Between April 1941 and April 1992, 521 patients
were referred to the echocardiography laboratory at New
York University Medical Center for transesophageal echo-
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Iowa ebeaft ) . Of 42 eaefrwl patients, 3 (7%) had
Vascular events (2 brdo, I eye) . Univeole analysis idnutiled only
tar°dhigw( romasassittdBwlgeorrelaingxhheventslp=
0.003) . There was no positive eareiation or errs with agcy
trade. hypeteasv, sarakiog, ray him", RUM bbrEWllon,
valve replacement, anti eeinbode drug me, diabetes
or eeruewy
dhme. ituhlvaehde nabob showed that only protruding other.
amae Independently peedchd events (p = 9.005, adds ratI 0.3,
95% eonfdeeee Interval 1 .2 to 15.0) . Nine patients died In the
alheruuta group seem sin In the taolml group, but this was aft
swtsticalh • Agailmnt (p = 0.39) .
Cowrlmia∎s. Prolradtg
otherwise
seen an trawsephageal
ehmardlogephy pndd future vmeutm Beds .
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cardiography. Protruding atheroms in the antic arch or the
dcacvndiosg thoracic aorta, or both . werefannd in 60 patients
(13%). Of these 68 patients with atheromas, 26 were ex-
cluded because of the presence of an additional possible
source of embolus (carotid distant . [21 patients] or Irons-
esophage i echocardiographic findings of spontaneous echo
contrast in the left atrium [2 patiaits], inracardiac thrombus
12 paticotsl and tumor of the aortic arch [1 patient)) . Patients
wish prosthetic valves were am excluded unless they also
had one of these findings
. The remaining 42 patients with
protruding atheromas and no other apparent source of
catbukrs famed tie study group
. An event consistent with a
systemic embolus (stroke, transient iachemic attack or pat
ripheral embalm) had occurred before the ttmsesophageul
echocardiogram in 28 of these patients The other 14 patients
with athermaa had no history of such previous events .
The 42 patients in the study group (26 men, 16 women,
mean age I±SD]
72 s 1 .5 years) were matched for age,
gender and presence or absence of hypertension (as defined
by history) with 42 control patients who had also undergone
inmsesophageal echocardiography, dating this period for
various indications other than embolic disease (valve disease
[21 patients]; to rule out endocarditis 14 patients], dissection
(4 patients], intracardiac mass [3 patients]
; to role not aortic
otherma before cardiopulmonary bypass [3 patients] ; coro-
nary artery disease 13 patients] ; and miscellaneous (5 pa-
0735-10a7N4K7.m
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Flow 1. Tap, Trons sophaged achocardiogmmorthe distal aortic
arch
. Nee the large athemma tint protnsdes into the lumen .
Borrow
Traraesopkageal echomrdbgam of a normal sonic arch
for comparison.
dental) . These 42 control patients had no protruding ashero-
mos, no history of carotid disease and no other etiology for
embolic disease awn on tranuesophageal echocardiography .
7rinamepigoel tdoeardlography . This procedure was
performed in the echocardiography laboratory in swab
patients with no premedicmion other than topical lidocaiee
spray. Images were obtained using a Hewett-Packand Sonos
1,W0 with a 5-MHz biplane transducm . The thoracic aorta
was fully explored in, all patients. including the ascending
aorta starting from the aurtic valve as stem on the vertical
view of the heat. The descending aorta and aortic arch were
visualized by relating the transducer toward the noun and
scanning from jut above the stomach uptoand indudingthe
sonic arch, which was visualized in two planes . Aortic
lesions were defined as potlud'mg atheromas (Fg . 1) if they
extended into the lumen x0.5 cm or if (here were associated
mo fide components . according to previously published cr(-
JACC Vol . 2r. No
. 5
Apil 1994:Imb.9a
leda (2,3). Diffuse intimal thickening or plaques without
mobile components that did cot protrude nO.5-cm did not
qualify for inclusion . Intmehserver and interobserver vari-
ability for the diagnosis of protruding atheromas in our
laboratory were
previously
evaluated and found to be mini
mal (2).
Bata .Beitca. AB patients were referred fortraosesoplr
ageal echocardiography by their private physicians . Clinical
btormadon was obtained from the patients as well as from
the hospital chins of inpssients at the time of tmnsesophs-
geal echoc ntiography. Patient enrollment in the study en-
compassed the I-year period noted previously. Follow-up
iaWrnmdon was obtained from the patients or from their
physicians or
hospital charts, or both, if the patients were
deceased . The tie to follow-up was noted as the number of
months between tmnsesophageal echocardiography and pa-
tient contact in 1943 or until the patient's death. Mean time
to Tallow-up was 13 months for patients with atheromia Read
14 months far control patents (range I to 24, p
-
0.50). No
paliceis were lost to follow-up.
Vammlar events daring fuBme-cep. The following events
were considered diagnostic of or consistent with vascular
events
: stroke (defined as a nestrologic event with permanent
deficit or computed tomagrapbic or magnetic resonance
imagi g evidence of cerebral ofarction, or both), transient
ischemic attack (deiced as a neardagic event with resolu-
tion within 24 M, amsureds, bowel infarction, renal failure
consent with atheroembolie disease (recent onset with no
other etiology) and acute isehemia of a limb or digit .
Statiakal
acoIllsis
. Analysis was done using BMDP
PC-90 soltsmse (BMDP Statistiad Software, In.).
(7nivmi-
ate analysis of aorpmmetric variables was done using
&I-agwte analysis. Age was compared using an unpaired,
twoaaied Sluderd t test. Multivariate andysh was done
udlizingthe Cox proportional hazards method . In assessing
the possible rmlnbut®n of variables to the development of
vascular events, variadm were screened for inclusion in a
model using chi-square analysis . Variables were included id
the model for Cox proportional hazards analysis if the p
value on univariate analysis was <0.1 . Odds ratios with 95%
confidence intervals wove calculated for the muhivariate
emiyses. A Kaplan-Major Bu;vivid analysis was done to take
into axons the variable follow-up limes. A power analysis
was done to
us en
the ability of the study to predict a
memdttghrl efieect of a baseline variable other than nthero-
mos, namely, hypertension (which was shown to have an
independent effect in our previous easetwtrol study) (2) . A
p value < 0.05 was considered to be sadistically significant .
Resu b
Bdefiae eiareeterlpka. By definition, the study group
with protruding atheromas and the control group were
matched for age, gender and presence or absence of hyper-
tension (Table I). There was no significant difference be-
tween the two groups with respect to the prevalence of
JACC Val. 23. No. 5
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Table 1
. Baseline Characteristics of Study and Control Patients
Values presented are mans value s SD M mrmaer 14) of patients
1414
.
AP = met Ohn6latitet PAP - parmtysmal axial 0hri0otioe .
coronary artery disease, diabetes mellitus, smoking history .
family history of atherosclerotic heart disease. atria) fibril-
lation (chronic or paroxysmal) or antithrombotic drug use
(aspirin or warfarin) .
Protruding aetle afternoons; en traosesophageal echacar-
dhgraphy. Protruding atheromas were present in the aortic
arch in 25 (60%) of 42 patients. There were mobile compo-
cents present in 9 (36%) of 25 arch atheromas . Protruding
atheromas were present in the descending thoracic aorta in
27 (64%) of 42 patients, and mobile components were
present in 8 (30%) of 27 descending aorta lesions . Providing
atheronms were present in both locations (arch and descend-
ing) in 10 (24%) of 42 patients . Mobile components were
present in half of these 10 patients, 3 with mobile compo-
Dents in both locations and 2 with mobile components in the
arch but not [n the descending aorta. By definition, none of
the control patients had protruding atheromas .
Vascular events timing follow-up . Fourteen (33%) of 42
patients with protruding alherum-- developed vascular
events during the follow-up period compared with only 3
(7%) of 42 control patients with such events (Tah!e 21 . This
difference was highly statistically significant (p < 0 .003).
Patients with atheromas had five brain events (three strokes,
two tra"sient ischemic attacks), four episodes of renal fail-
ure, one bowel infarction, two cases of visual disturbance
(rule of which was a permanent sequels of heart surgery) and
seven episodes of lower extremity ischemia (three of which
required toe amputation). All four episodes of renal failure
occurred in association with lower extremity ischemia, and
three of these four patients died (one of whom also had
bowel lnfaictlon). The three vascular events In the control
group consisted of two strokes (one fatal) and one episode of
antaurosis fogies. The average time until a vascular event
occurred was 10 months. Patients without events were
followed up for an average of 14 months .
Balladeer between protruding aortic atheromas and other
bmdloe eharaeter191n and vascular events during follow-up .
Univariate analysis of baseline variables showed that only
protruding aortic atheromas were significantly related to the
'P r O.W3 . (attests with mheronms versus control patients . Rls). Pls =
70110050).
development of vascular events (p = 0 .003) . There was no
significant positive correlation of events with age, gender .
hypertension, diabetes, coronary artery disease, smoking,
family history of coronary artery disease . atrial fibrillation,
valve replacement or antithrombotic drug use . The power of
this study to detect a significant effect of these other baseline
variables was low (from 0.15 to 0
.52)
. However, the care'
latiun coefficients of these other variables with subsequent
vascular events were only 0 .03 to 0.2 .
On multivariate analysis, diabetes and coronary artery
disease had p values > 0.05 (0.08 and 0 .06) but <0.10.
Therefore, these two variables were included with protrud-
ing atheroaas in a Cox proportional hazards analysis to
assess whether protruding atheromas independently pre-
dicted vascula7 events. The results showed that only pro-
truding atheromas signiilcantly predicted the development of
vascular events (odds ratio 4 .3, 95% confidence interval [C1)
1 .2 to 15 .0. p = 0.005). An additional analysis was done that
included age, gender, coronary artery disease, hypertension,
smoking history, family history . aerial fibrillation, antithrom-
botic drug use and protruding atheromas in the model . Even
after controlling for all of these variables, protruding ather-
omas still independently predicted vascular events (odds
ratio 4 .6, 95% C1 1 .1 to 18 .9. p = 0.01), and there was no
significant correlation with any of the other variables. Spe-
cifically, warrarin use (which may have been expected to
Pea With
Adeaauas
(n - 421
Control Pit
(n = 42) p Value
Men 26(61%) 26 (62'0)
1
.9
Age (Yr) 7'- ± 1
s
74) x 1,4 0 .38
Hypermmiao 20418%1 20(45%) 1 .0
Carsemy artery disease 19143.41 14037b 0.26
Diabetes 8119041 5U2%] 0.37
SmImhing 33179)41
25(60%)
0.06
FamilyhinMy 11(22654) 10)24%)
0
.80
AF ar PAF 0(19"01
12(25%) 0,31
Andthrombmk drug use 26 )62%)
33 05%) 0 .51
Valve Prosthesis 3 (7%t
13 111 ,41
0,011
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Table 2. Patients With Vascular Events During Follow-Up*
Location
Pt
No Gender Brain Kidney Bowel Eye Lxe
Pte alto ntheromas
114i5c) Ia)4 2 1
NF x
7,
M
aF
a 5
1131
481
lots
z
'_391 x
33,
•61
35:61
3151,1
40'0 z
4LP a
Tsnal
Cnn,rol plc
5 I - 7
13 G" )>of421
58 :61
57N
ant
z
robot 2 0 0 I 0
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protect against events) was virtually identical in both groups
at follow-up (21 patients with atheromas, 22 control sub-
jects) . Aspirin use was also similar in both groups (16
patients with atheromas, I I control patients) . The incidence
of events in the patients with arhemmas receiving wariein
was 33% (7 of 21 patients), not significantly different from
that in patients receiving aspirin (4 at 125%) 16 patients) or
to amithrombolic drugs (5 150%1 of 10 paients). Finally,
Keplan-Meier survival analysis showed that the patients
with atberumas had significantly more vascular events than
did control patients (P
-
0 .007).
Dmthr . Mme patients with protruding atheromas died
then control patients (nine 121%1 vs . six (14%1, respective •
ly); however, this difference was not smt(stkally significant
(p = 0.39) . In me nine patients with atheromas, death was
related to vascular events (five patients), including fatal
strokes (two patients) and multiple argon ischemia (three
patients), as noted earlier. The other four patients with
atheronas died of causes with no clear relation to their aortic
atherumns, including sudden death (one pedant), congestive
heart failure (one patient), pulmonary embolus (one patient)
and bleeding complications after heart surgery (one patient)
.
to the six control patients who died, death was due to
nonembalic complications of heart surgery (two patiestts)
and stroke, myocardial infarction, ventricular fibtifatiest
(due to narcoid heart disease) and stomach carcinoma (one
patient each). Thus, the incidence of death related to Vascu-
lnrevents was higher in patients with atheromas (five of nine
(56%) vs . one 117%) of six) than in the control group . This
trend did not reach statistical significance (p - 0,09).
Other wkema, There were no myocardial intarcttom
during the fellow-up period in the 42 patients with protruding
atheramas
; there was an (ftal) infarction in the control
patients. Significantly, more control patients had )eat surgery
(15 135%) of 42 vs 4 [10%] of 42 patients with atheromas .
p = 0 .004) . Seven (17%) of the 42 patients
with stheramas
and none of the control patients had vascular surgery (p
0
.006)
. Only one patient was operated on to prevent ernbo .
ilzatiao (aortic arch endartereciomy, with no thrombo-
embolic complications of surgery sad none in follow-up),
and he died suddenly at 0 months .
Analysis o patients with
protruding
alitne mm and m
previuss hstaryyo
emholk events. Fourteen patients (33%)
In the group with protruding alheromas did not have a
history of stroke. transient isciemie attack or periphesal
embolus before transeaophageal echocardiography
. These
patients had been referred for ttansesepkagast echocardiog
rophy because of valve disease (eight patients), possible
endocarditis (four patients, studies negative for vegetations),
coronary disease (am patient) and to role out aortic athero-
man before ardiopulmonary bypass (one patient) . Vascular
events during the Now-up period occurred in 6 (43%) of
these 14 patients
. One patient died alter bowel, renal and
lower extremity ischemia
. There were five other events,
involving the legs (two tandems), the eye (two patients) and
the brain (one patient). The average up o these 14 patients
1ACC Yd D, Nw 5
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was 74 ± 1 .8 years (p = KS vs. control group) . Unwanate
analysis idea ied providing atheromas (P = 0.0021 and
diabetes (p • 0.04) as significant correlates of these future
vascular events. There was no significant correlation of the
other baseline variables with these events. Multivariate
analysis with atheromas and debates in the model
showed
that diabetes did not contribute independently to the devel-
opment of vascular events (p = 0.00) . whereas protruding
atheromas were independently and still highly correlated
(odds refo 6.0, 95% Cl 1 .5 to 24
.7. p = 0
.009).
Discussion
In a previous retrospective study (2) . we analyzed 122
patients with protruding aortic atherontas who were referred
for rransesophrgeal echocardiography because of stroke .
transient ischemie muck or p'dphenl embolizatioa be-
tween 1998 and 1990. These patients were age and gender
matched to 122 control patients who bad transesophageal
echocardiography during the same time period far indica-
tions other then embolic syndromes . These was no overlap
of patients with those in thenwrent study . The odds ratio for
the occurrence of prior symptoms is the presence of pro-
trading atheromaa was 3 .2 (95% Cl 1.6 to 6.5, p e 0.001).
Thai canecontrd study concluded that protruding athero-
naae in the thoracic aorta as seen on nansesaphageal
echo-
cardiography
should be comiderod as a cane of strokes,
ttatnient ixkaic
attacks
and peripheral embdlaatlon. A
similar association betwea prdnrdng aoetk atheroman and
spontaneously occurring embolic
daease was reported by
Kmdia et d. (3) In 1991 and by Awassence et all . (7) and
Toyoda d al . (a)
in
192
. Protruding aortic mheronas have
also been implicated in embolic events caused by
wWeter-
Ization and anpapapky, and the placement arm larsaonic
balloon pump any dislodge debris4om these lesions as well
(3 .9) . However, to data them hen been no pnospalive study
of pademswith protnaliag aortic atheromas to determine the
risk of (owe clinical consequences In these patients .
Stroke has remained a significant complication of cardiac
surgery,
ad
the incidence of perioperatwe stroke due to
procedures requiring cardiopulmonary bypass ban been re-
period to rage from 2% to 5% entered (10, 1 1) and 7% In one
series opmicnts >70 yeas old (12) . In areecnt study (6). we
used imnapemtive tansesophagesl echocadiography to
study 130 patients over the age of 65 during bean surgery.
Twenty-three (1a%) of these patients had protruding athero-
roes in the aortic arch. The study showed that the incidence
of stroke was significantly higher in the patients with pro-
trading athaomas.
Fathologic coofirmaticn that atherosclerotic lesions in the
thoracic aorta an stronyay associated with stroke has re
candy been reported by Amarenco et al . (13) who analyzed
autopsy findings in 500 patients with cerebrovascular or
other neurologic diseases. They found that ulcerated plaques
iACC Val. 27 . No . 5
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were present infix thoracic aorta of 26t1 of 239 patients with
eerebrovascular disease, but they were seen in only 5% of
261 patients who had died of other neurologic diseases .
The composition of the protruding athcrumas seen on
transesopbageal echocardiogmly has been established in
only a few cases . Material removed from the aortic arch at
surgery was atherclerotic plaque with small amounts of
superimposed thrombus in one patient 1141 and a shallow
ulcerated plaque in the aortic arch with a very large super-
imposed thrombus in another (151 . These findings correlated
well with the transesophageat edmcardiographic findings of
a large protruding atheroma with a small mobile component
in the first patient and a small fixed lesion with a very large
mobile component in the second . Embolic material removed
from the femoral arteries of both of these patients was
thrombus. However, the classic syndrome of atheroemboli
has been that of cholesterol emboliration, which may in-
volve the eyes (16.17). bowel (LB), kidneys (19) and legs .
causing the blue toe syndrome (20)
.
Embolization of choles-
terol crystals has been documented in quadriceps muscle .
foot and renal biopsy specimens obtained from several
patients with renal and lower extremity ischemia who had
protruding aortic atheroams seen on transesophageal
echo-
cardiography
(7.21,22) . Therefore, there are at least two
types of arterioorterial embolic disease in patients with
prttuding atheromas. The mobile components of the lesions
seen on transesophageal echocardiography, which may rep-
resent thrombus, can embolize to larger arteries, causing
stroke . limb ischemia or infarction of other organs. In
addition, diffuse cholesterol emhdizmion to smaller arteries
may occur, resulting in renal failure and the blue toe syn-
drome. Embofization of larger atheraaatoua sasses, or a
cambitmtioo of Were syndromes, is also theoretically possible .
To further investigve the relation between protruding
ache omas in the thoracic aorta and vaacntat events . and to
overcome the inherent limitations of previous retrospective
analyses, the current study was designed m prospectively
follow up patients with protruding alhmomas. A large num-
ber of vascular events occurred in a relatively short
follow-up period. Both mtivariato and mullivariate analysis
demonstrated that the presence of protruding atheromas
predicted these events. hone of the other baseline variables
listed in Table I was a significant independent predictor or
future vascular events (prosthetic valves, which may be
potential embolic sources. were more common in the control
group and were negatively correlated with future vascular
events). Furthermore, in five of the nine patients with
protruding atheromas who died, death may have been re-
lated to the Lesions found in the aorta by trattsetaphageal
may. Finally, even among those study patients
with no previous vascular events, she risk of such events was
BF-
Study
raaiahoas. A problem exists in assigning a cause
for vascular events in general, and this holds true for the
TUNICK Er AL.
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patients in this study
. The presentations of thrombotlc and
embolic events may be largely the same (23).
This study involved imaging of the thoracic aorta only .
Atherosclerosis of the lower extremity vessels may further
complicate the issuen patients with lower extremity embo-
liration
. Lower extremity vascular e•ents occurred in seven
patients in the study, however, four of these also had renal
failure . including one who had bowel infarction as well
. In
all, there was a history
ofperipheral vasculardisease involv-
ing the lower extremity arteries in 21 of the 42 patients with
protruding mherornas of the thoracic aorta. Although in.
volvement of the lowerextrematy arteries obviously does not
explain the brain. eye. renal and bowel events in this study,
it is not possible to say what rob intrinsic disease of the
lower extremity arteries played in those patients with lower
extremity vascular events .
Another limitation is that many of the patients in the
study had previous vascular events, which may themselves
he risk factors for future events, However, when the group
with no previous vascular events was analyzed separately,
there was still a strong correlation. The relatively small
number of patients in this group is also a limitation of the
study.
Transesophageal echocardiography, may miss a small area
of the aorta that is masked by the air column in the trachea,
and this may have reduced the number of protruding other-
omas found . However, ready all of the thoracic aorta is well
visualized by transesophageal echocardiography . In addi-
tiorl, the echocardiograms in this study were done with a
biplane probe . it is possible that the use of a multiplune
transducer would have Increased the yield somewhat .
Variables other than atherumes did not predict vascular
events. However. because of the sample size, the power of
the study to exclude a clinically meaningful effect of the
other variables was not high . However, the very low corre-
lation coefficients of these other variables, which would not
increase with a larger sample size, indicate that any effect
measurable with a larger study would he very small and
would require 900 to 1 .000 patients to be statistically detect-
able.
It has been recently demonstrated that atherosclerotic
aortic plaque seen on Iransesophageal edrocatdiography is a
marker for coronary artery disease (24), and current obser-
vations in our laboratory indicate that protruding aortic
atheromas ace common in symptomatic patients with carotid
artery disease. Although protruding atheromas in the tho-
racic aorta may will be a marker for diffuse Atherosclerosis,
they are likely to be a source of emboli as well.
Caodusiom. Patients with protruding aortic atheriamas
seen on transesophageal echocardlography are at high risk
for the development of vascular events, including transient
ischemic attack, stroke, visual impairment, renal failure,
lowerextremity ischestiaand death due to ischemic multiple
organ failure.
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